Name
AS Lõuna-Eesti Haigla
Registry code
10833853
VAT number
EE100869015
Type
AS - Joint Stock Company
Status
Registered
Foundation date
31.12.2001 (23)
Financial year
01.01-31.12
Capital
1 214 163.90 €
Activity
86906 - Activities of diagnostic cabinets and centres, e.g. X-ray laboratories, magnetic resonance imaging and other similar cabinets 86221 - Provision of specialised medical treatment 86901 - Activities of emergency medical staff and paramedics
-
-
-
-
-
-
-
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| sihtasutus Tartu Ülikooli Kliinikum 90001478 | 51% - 619 191.00 EUR | - | - | Shareholder |
| Võrumaa Omavalitsuste Liit 80194583 | 49% - 594 972.90 EUR | - | - | Shareholder |
| Arvi Vask
| - | Board member | - | |
| Priit Süüden
| - | - | - | Board member |
| Rein Järvelill
| - | - | - | Board member |
| Kadri Piir
| - | - | - | Board member |
| Rasmus Pikkani
| - | - | - | Board member |
| Andres Visnapuu
| - | - | - | Board member |
| Toomas Ellervee
| - | - | - | Chairman of the board |
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Pesuring OÜ 11285842 | 100% - 6 400.00 EUR | - | - | Founder |
| osaühing METSAKOHVIK 11005420 | 100% - 59 891.00 EUR | - | - | Founder |
| Sihtasutus Võru Pensionäride Päevakeskus 90007721 | - | - | - | Founder |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q4 | 39 346.94 € | 1 480 748.14 € | 1 571 434.47 € | 524 |
| 2024 Q3 | 29 007.8 € | 1 622 438.35 € | 1 723 317.98 € | 519 |
| 2024 Q2 | 35 894.84 € | 1 429 851.1 € | 1 517 424.53 € | 519 |
| 2024 Q1 | 44 895.75 € | 1 388 152.76 € | 1 472 435.74 € | 517 |
| 2023 Q4 | 44 649.04 € | 1 305 328.6 € | 1 385 699.27 € | 519 |
| 2023 Q3 | 34 558.95 € | 1 426 491.88 € | 1 515 626.06 € | 511 |
| 2023 Q2 | 28 922.01 € | 1 230 580.26 € | 1 308 138.33 € | 503 |
| 2023 Q1 | 45 100.22 € | 1 230 216.16 € | 1 304 879.47 € | 490 |
| 2022 Q4 | 40 679.01 € | 1 102 676.35 € | 1 171 634.1 € | 497 |
| 2022 Q3 | 33 078.27 € | 1 232 950.92 € | 1 312 624.81 € | 497 |
| 2022 Q2 | 29 630.56 € | 1 114 580.55 € | 1 185 677.63 € | 494 |
| 2022 Q1 | 37 647.31 € | 1 156 235.45 € | 1 231 823.85 € | 476 |
| 2021 Q4 | 29 983.83 € | 985 649.11 € | 1 050 971.57 € | 493 |
| 2021 Q3 | 25 397.31 € | 1 099 041.03 € | 1 179 516.85 € | 496 |
| 2021 Q2 | 30 922.61 € | 1 023 130.17 € | 1 096 399.08 € | 496 |
| 2021 Q1 | 23 745.73 € | 1 061 596.78 € | 1 139 302.62 € | 485 |
| 2020 Q4 | 53 149.2 € | 900 304.25 € | 959 879.52 € | 473 |
| 2020 Q3 | 34 980.97 € | 996 040.23 € | 1 067 264.53 € | 459 |
| 2020 Q2 | 44 644.87 € | 855 773.07 € | 912 909.5 € | 463 |
| 2020 Q1 | 25 694.27 € | 839 310.48 € | 898 903.51 € | 439 |
